Ledger.Open graph →
SEC Form D · Amendment · filed May 3, 2010

NGM BIOPHARMACEUTICALS INC

Offering
$55.7M
Sold
$21.5M
Exemption
—
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

People & firms on this filing (17)

Marc Leschly · Palo Alto, CADirectorPeter Svennilson · Gulf Stream, FLDirectorJames J. Lynch · HARTFORD, CTExec · DirectorHelen Kim · South San Francisco, CAExecLuis Bayol · South San Francisco, CAExecMichael Hormaechea · Boise, IDExec · DirectorArthur D. Levinson · South San Francisco, CADirectorGail Naughton · Encinitas, CADirectorSteven J. Kapiloff · HARTFORD, CTDirectorMonika Wingate · Madison, WIExec · DirectorJane Boutelle · Madison, WIExec · DirectorElliott Elbaz · Mill Valley, CADirectorKyle Cummings · Sisters, ORExecRobert Pinnick · Bend, ORExecRajan Sobhani · Plano, TXDirectorRavi Mohan · Menlo Park, CADirectorFrank G. Mazzola · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗